ISS Recommends Aurora Shareholders Vote For All Proposals at 2026 AGM

Aurora Cannabis Inc., a Canadian-based global medical cannabis company, announced that Institutional Shareholder Services Inc. (ISS), an independent proxy advisory firm, has recommended its shareholders vote FOR all proposals at the upcoming 2026 Annual General Meeting of Shareholders. The recommendation covers all director nominees and resolutions presented at the meeting.

ISS is a prominent independent proxy advisor whose recommendations are widely relied upon by major institutional investors. Miguel Martin, Aurora's Executive Chairman and CEO, welcomed the ISS recommendation, stating it reflects the company's strong governance framework and board oversight. "We appreciate our shareholders' trust and support as we continue to expand our global medical cannabis business and focus on building long-term value," Martin said.

The meeting will be held virtually on Friday, August 7, 2026, at 1:00 p.m. (Eastern Time) / 11:00 a.m. (Mountain Time). The virtual format allows for shareholder participation regardless of location. Shareholders are encouraged to vote early in favor of all resolutions, as every vote matters. The deadline to vote shares is Wednesday, August 5, 2026, at 1:00 p.m. (Eastern Time).

At the meeting, shareholders will be asked to elect five directors, appoint the auditor, and vote on a non-binding advisory resolution regarding executive compensation. Aurora Cannabis operates in the medical cannabis sector globally.